Evidence map›Paper›PMID 33179012›Full record

ArticleJournal of cancer science and clinical therapeutics2020

S179D Prolactin Sensitizes Human PC3 Prostate Cancer Xenografts to Anti-tumor Effects of Well-Tolerated Doses of Calcitriol.

Christopher T Holland, Joffrey Hsu, Ameae M Walker

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer science and clinical therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher T HollandDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.
Joffrey HsuDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.
Ameae M WalkerDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.
University of California, Riverside · US

Funding

Genetic approaches to study cytokine control of metabolismZ01DK061005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HENNIGHAUSEN, LOTHAR · 2007 to 2008
$1.3M
S179D Prolactin: Inhibition of Prostate Cancer GrowthR01DK061005 · NIDDK · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI WALKER, AMEAE M · 2001 to 2004
$1.1M
Intramural NIH HHS Z01 DK061005NIDDK NIH HHS R01 DK061005
6 · The paper itself

Abstract

Calcitriol has been shown to have multiple anti-prostate cancer effects both

Indexed as

Anti-angiogenesisApoptosisDual therapySelective Prolactin Receptor Modulatorsynergy

Identifiers

PMID33179012
PMCPMC7655011
OpenAlexW3087858365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.